Cargando…
Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
Metabolism-disrupting chemicals (MDCs) are endocrine disruptors with obesogenic and/or diabetogenic action. There is mounting evidence linking exposure to MDCs to increased susceptibility to diabetes. Despite the important role of glucagon in glucose homeostasis, there is little information on the e...
Autores principales: | Dos Santos, Reinaldo Sousa, Babiloni-Chust, Ignacio, Marroqui, Laura, Nadal, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820113/ https://www.ncbi.nlm.nih.gov/pubmed/36613676 http://dx.doi.org/10.3390/ijms24010231 |
Ejemplares similares
-
In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model
por: Dos Santos, Reinaldo Sousa, et al.
Publicado: (2022) -
BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis
por: Perez-Serna, Atenea A., et al.
Publicado: (2023) -
Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes
por: Bru-Tari, Eva, et al.
Publicado: (2019) -
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults
por: Dos Santos, Reinaldo S., et al.
Publicado: (2023) -
Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
por: Al-Abdulla, Ruba, et al.
Publicado: (2022)